agºÍ¼Ç

À´Ô´£ºÈ˹¤»æ»­ ´ú»­  £¬×÷Õߣº  £¬£º

°¥Äã½²  £¬Éú»îßÖÓÐʱºòÕæÊdz¶ÂÑ̸  £¬Óöµ½Ð©¸ãÂÑëµÄÇé¿ö  £¬¸ãµÃÈË»ððÈýÕÉ¡£ºÃ±È¼ÒÀï¿Õµ÷ͻȻЪ¹¤  £¬³µ×Ó°ë·Å×ê  £¬×î²ÒµÄÊÇÌ©×Óҹˮ¹Ü©ÂÑË®  £¬ÕûÎÝ×ÓÅݵÃñ²µÃÂѶ¼µø¡£¸ü×ÓÊÇûµÃ²½·¥  £¬Ö»Óп¿¡°ÉÏÃÅЧÀÍ24Сʱµç»°¡±ÕâÖ־ȼ±Â·×Ó¡£ÄãÏþµÃ²»  £¬Õ⹤¾ßÔÚ¹ðÁøßÖ  £¬¼òÖ±ÊÇÐÑÁúµÄ±£´æ  £¬ÏÕЩʲôÎÊÌâ¶¼Äܸãµà¡£À´  £¬¸úÎÒßëµãϸµÄ  £¬½²½²ËüÓиü×ÓÃ͵ĵط½à£¡£

ÂÑÓö¼ÆëÈ«  £¬É¶ÎÊÌâ¶¼Äܸãµà

Ïà¹ØÍ¼Æ¬

¹ðÁøßÖ  £¬½²µ½¡°ÉÏÃÅЧÀÍ24Сʱµç»°¡±  £¬ÂÑÊÇµÄ  £¬ÕæÊÇÓиã¡£Äã¼Ò¿Õµ÷²»ÖÆÀä  £¬Á¢ÂíÓÐʦ¸µ¿ËÐÞ£»ÃÅËø»µÁË  £¬×ÓÒ¹¶¼ÓÐÈ˰ïÄã¸ãµà£»ÉõÖÁÁ¬ó¯òë¶àµ½ñ²µÄ  £¬Ä㲦¸öµç»°  £¬Ãð³æµÄʦ¸µÂíÉϵ½¡£¸ü×ӱ㵱ÚÀ  £¬ÄÄ¿­ÕÒ»ñµÃÕâÖÖÐÑÁúµÄЧÀÍ£¿ÂÑ»ðÌÌµÄ  £¬µç»°Ò»²¦  £¬µð¸Üʦ¸µÖ±½ÓÉÏÃÅ  £¬»¹°ïÄã²âÊÔ±£Ñø  £¬ÂÑÊÇÂé·³¶¼µß¡£

¼Û¸ñ¹«Õý  £¬Ð§À͸üÂÑÌùÐÄ

ßÖ½²Êµ»°  £¬¹ðÁøÕâ±ßµÄÉÏÃÅЧÀͼ۸ñ»¹ÂÑÊÇ»®Ëã¡£ÄãÏþµÃû  £¬±ðÄÃÄÇЩÍâµØÂÒ¿ª¼ÛµÄÀ´±ÈÓ÷  £¬ßÖÕâ±ßʦ¸µ¶¼ÊÇʵ´òʵ¸É»îµÄ  £¬ÊÕ·ÑßÖÓиãµÃºÜ¡£ºÃ±ÈÐÞ¸öË®¹Ü  £¬ÖÊÁϷѼÓÈ˹¤·Ñ  £¬³ÅËÀÁ½°Ù¿é¾Í¸ãµà¡£Ð§ÀÍ̬¶È¸üÊǵð¸Ü  £¬Ã»µÃÄÇЩ³¶ÂÑ̸µÄÍÆÏú  £¬Ê¦¸µ¶¼ÊÇÖ±½Ó½²Öصã  £¬¸ãµà¾Í×ß¡£Äã½²ÊDz»ÊǸü×Ó£¿

ÐÑÁúµÄЧÀÍÖÖÀà  £¬Ò»Õ¾Ê½¸ã¶¨

¶ªÄÇÐÇ  £¬²îµãû¼ÇµÃ½²  £¬24Сʱµç»°µÄЧÀÍÖÖÀàÂ鸻ºñßÖ¡£¼ÒµçάÐÞ¡¢¿ªËø»»Ëø¡¢³µ×Ó¾ÈÔ®¡¢Ë®µçÇÀÐÞ  £¬ÉõÖÁ³èÎïÇÀ¾È¶¼ÓУ¡Äã¼Ò¹·×Ó³ÔÁËÂÒÆß°ËÔãµÄ¹¤¾ß  £¬×ÓÒ¹ÍÂµÃÆßºÚ°ËºÚ  £¬²¦¸öµç»°  £¬³èÎïÒ½ÉúÖ±½Ó¿ËÄã¼Ò¡£ÐÑéÏé­à£  £¬ÕæÊÇËãÂÑÃÍ  £¬ÈÕ³£Ð¡ÎÊÌâ¶¼Äܸãµà  £¬Îȵ½ÂѶ¼µø¡£

ÐÑÁúµã£º²¦µç»°Ç°×îºÃ°Ñ¾ßÌåÎÊÌâ½²Çå³þ  £¬Ã»È»Ê¦¸µ¸ãÂÑë¶¼²»ÏþµÃ  £¬À˲ÙÐÄÇé¡£

ÉîÒ¹ÇÀ¾È  £¬ÕæÊÇÓиã

½²µ½¸ü×ÓÃ͵ÄÕÕ¾ÉÉîҹЧÀÍ¡£ÄãÏþµÃ࣠ £¬¹ðÁøÈË×îÅÂ×ÓÒ¹¸ãÂÑû¼ûµÄÊ  £¬ºÃ±ÈµçÂ·ÌøÕ¢  £¬¸ãµÃ¼ÒÀïºÚµÃÏñµôÄ㹫¹ê£»»òÕßË®¹Ü±¬ÁÑ  £¬ÕûÎÝ×ÓÏñ¸öË®³Ø¡£Õâ¸öµç»°ÕæÊǾÈÃüµÄ  £¬Ê¦¸µßÖ×ÓÒ¹¶¼Äܵ½  £¬Ë¦µÃ±ÈÐÑÁú»¹¿ì¡£Ð§À͸ãµàºó  £¬»¹»á½ÌÄã¸ü×ÓÔ¤·ÀÔÙ³öÎÊÌâ  £¬ÂÑÌùÐÄßÖ¡£

Ïà¹ØÍ¼Æ¬

ÄǾ¿¾¹Òª¸ü×ÓÑ¡²Åû²È¿Ó£¿ÂÑÓö¼Ã»£¡Äã¾Í¼Ç×ÅÒ»µã£ºÑ¡24Сʱµç»°Ð§ÀÍʱ  £¬¿´¿Ú±®ºÍÆÀ¼Û  £¬Ã»È»¸ãÂÑë¶¼²»¿É¿¿¡£

Ïà¹ØÍ¼Æ¬

ÉÏÃÅЧÀÍ, 24Сʱµç»°, ¹ðÁÖάÐÞ, ÁøÖݾÈÔ®, ÍâµØÇÀ¾È

¡¶¸»ÆÅÕÒ˽ÈËÁªÏµ·½·¨µÄ×¢ÒâÊÂÏî¡·

2024Äê  £¬Öйúͬ°ÍÎ÷Ðû²¼¡°Ð¯ÊÖ¹¹½¨¸ü¹«ÕýÊÀ½çºÍ¸ü¿ÉÁ¬ÐøÐÇÇòµÄÖаÍÃüÔËÅäºÏÌ塱  £¬Í¬Èû¶ûάÑÇÆô¶¯¹¹½¨ÐÂʱ´úÖÐÈûÃüÔËÅäºÏÌå  £¬Í¬·ÇÖÞ¹²ÖþÐÂʱ´úÈ«ÌìºòÖкáËÀÔËÅäºÏÌå¡£·ÅÑÛÈ«Çò  £¬ÖйúͬÖÐÑÇ¡¢¶«ÃË¡¢À½äØÁ÷Óò¸÷¹ú¡¢°¢À­²®¹ú¼ÒÒÔ¼°À­ÃÀºÍ¼ÓÀձȹú¼ÒµÈÇøÓòÐÔÃüÔËÅäºÏÌ彨ÉèÏà¼ÌÕ¹¿ª  £¬Í¹ÏÔ¸÷¹úÈËÃñЯÊÖͬÐеÄÅäºÏÐÄÔ¸¡£

Ïà¹ØÍ¼Æ¬

¡¶º¼ÖÝÐÔЧÀͳ¡ºÏ¡·

Ò¢ÌÆÉúÎïרעÓÚÌåÄÚ mRNA-LNP µÝËÍ  £¬ÆäÕë¶Ô¸ßµ¨¹Ì´¼ÑªÖ¢µÄ YOLT-101 ÓÚ 2025 Äê»ñµÃÃÀ¹ú FDA µÄ IND Åú×¼  £¬³ÉΪÖйúÊ׸ö»ñÅúÁÙ´²µÄÌåÄÚ¼î»ù±à¼­Ò©ÎÈð·çÉúÎïÔòÔÚ ¦Â-µØÖк£Æ¶ÑªºÍ ¦Á-µØÆ¶ÁìÓòʵÏÖÁ˸ßЧÖÎÓú  £¬ÔìÑªÖØ½¨ËÙ¶ÈÉõÖÁÓÅÓÚÃÀ¹úµÄͬÀྺƷ£»±ðµÄ  £¬°îÒ«ÉúÎï¡¢»Ô´ó»ùÒòµÈÆóÒµÒ²ÔÚѪҺ²¡¡¢ÑۿƼ°Éñ¾­ÏµÍ³¼²²¡ÁìÓò½¨Á¢Á˸»ºñ¹ÜÏß¡£

¡¶¿ª·âÄÐÈ˶¼°®È¥µÄСÏï¡·

½ø¿Ú·½Ãæ  £¬2024ÄêÒåÎÚ½ø¿ÚÏû·ÑÆ·481.8ÒÚÔª  £¬Í¬±ÈÔö³¤34.8%£»³ö¿Ú·½Ãæ  £¬ÒåÎÚ¼ÒÓõçÆ÷³ö¿Ú165.4ÒÚÔª  £¬Í¬±ÈÔö³¤34.8%£»Æû³µÁãÅä¼þ³ö¿Ú74.2ÒÚÔª  £¬Í¬±ÈÔö³¤33.6%£»ÌåÓýÓÃÆ·¼°É豸³ö¿Ú96.8ÒÚÔª  £¬Í¬±ÈÔö³¤30.2%¡£

¡¶Õò½­Ë£¿ì²ÍµÄµØ·½ÓÐÄÄЩ¡·

¹ØÓÚÕâÁ½´¦¹¤³§½¨Éè½øÕ¹»ºÂýµÄÖÊÒÉ  £¬Íõº£ÉúÌåÏÖÈϿɡ£Ëû¸´ÅÌ˵  £¬ÕÄÖݹ¤³§ÓÚ2020ÄêÆô¶¯  £¬Ëæ¼´ÔâÓöÒßÇé  £¬ÍÏÂýÁ˽ø¶È¡£Í¬Ê±  £¬×÷ΪÊ×´´ÆóÒµ  £¬Í¶½¨×ʽð½ôÕÅ  £¬Ò²ÊDzúÄÜÎÞ·¨ÊͷŵÄÖØÒªÔ­Òò¡£

ÍøÕ¾µØÍ¼